Nektar Therapeutics

NKTR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-8 Oct 20, 2026 REGISTRATION STATEMENT
8-K Oct 1, 2026 CURRENT REPORT
SCHEDULE 13G/A Sep 28, 2026
4 Sep 25, 2026 4
4 Sep 25, 2026 4
4 Sep 25, 2026 4
4 Sep 25, 2026 4
4 Sep 25, 2026 4
8-K Sep 25, 2026 CURRENT REPORT
8-K Sep 8, 2026 CURRENT REPORT
4 Aug 20, 2026 4
4 Aug 20, 2026 4
144 Aug 18, 2026
144 Aug 18, 2026
SCHEDULE 13G/A Aug 14, 2026
S-8 Aug 14, 2026 REGISTRATION STATEMENT
SCHEDULE 13G/A Aug 14, 2026
10-Q Aug 14, 2026 10-Q
8-K Aug 13, 2026 CURRENT REPORT
SCHEDULE 13G Jul 31, 2026
SCHEDULE 13G Jul 29, 2026
4 Jul 24, 2026 4
4 Jul 24, 2026 4
4 Jul 2, 2026 4
144 Jun 30, 2026
← Newer Page 1 of 76 · 1898 filings Older →